Bookbot

Sickening

Ocena książki

Parametry

  • 336 stron
  • 12 godzin czytania

Więcej o książce

This exposé reveals how Big Pharma’s relentless quest for profit distorts medical knowledge, misguides doctors, and jeopardizes public health. The U.S. spends over $1.5 trillion annually on healthcare yet ranks a dismal 68th globally in healthy life expectancy. Central to this issue is Big Pharma's dominance over clinical trials, which they fund and control, often keeping critical data secret and influencing the information that healthcare professionals rely on. Dr. John Abramson, an expert on the drug industry’s misleading practices, combines patient narratives with insights from years of involvement in national drug litigation to uncover the financial entanglements that contribute to healthcare dysfunction. Notably, peer reviewers tasked with validating clinical trial reports lack access to complete data, relying instead on summaries shaped by manufacturers. This also applies to experts drafting clinical practice guidelines that set care standards. Drawing from extensive research and insider knowledge of the U.S. medical-industrial complex, this work illuminates the troubling realities of American healthcare and offers a roadmap for meaningful reform.

Wydanie

Zakup książki

Sickening, Zelda Abramson, John Lynch

Język
Rok wydania
2023
Oprawa
(miękka)
Jak tylko się pojawi, wyślemy Ci wiadomość e-mail.

Metody płatności

4,2
Bardzo dobra
1054 Ocena

Brakuje nam tutaj Twojej recenzji.

Tytuł
Sickening
Język
angielski
Rok wydania
2023
Oprawa
miękka
Liczba stron
336
ISBN10
0063268728
ISBN13
9780063268722
Seria
Ocena
4,2 z 5
Opis
This exposé reveals how Big Pharma’s relentless quest for profit distorts medical knowledge, misguides doctors, and jeopardizes public health. The U.S. spends over $1.5 trillion annually on healthcare yet ranks a dismal 68th globally in healthy life expectancy. Central to this issue is Big Pharma's dominance over clinical trials, which they fund and control, often keeping critical data secret and influencing the information that healthcare professionals rely on. Dr. John Abramson, an expert on the drug industry’s misleading practices, combines patient narratives with insights from years of involvement in national drug litigation to uncover the financial entanglements that contribute to healthcare dysfunction. Notably, peer reviewers tasked with validating clinical trial reports lack access to complete data, relying instead on summaries shaped by manufacturers. This also applies to experts drafting clinical practice guidelines that set care standards. Drawing from extensive research and insider knowledge of the U.S. medical-industrial complex, this work illuminates the troubling realities of American healthcare and offers a roadmap for meaningful reform.